AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Bio Green Med Solution, Inc.
  3. Financials
  4. Research & development

Bio Green Med Solution, Inc.【BGMS】

Market cap
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 20247-65.26%
Dec 31, 202319-5.52%
Dec 31, 202220+30.99%
Dec 31, 202115+225.22%
Dec 31, 20205+2.17%
Dec 31, 20195+7.65%
Dec 31, 20184+2.12%
Dec 31, 20174-55.29%
Dec 31, 20169-23.46%
Dec 31, 201512-32.25%
Dec 31, 201418-91.03%
Dec 31, 2013204+5.86%
Dec 31, 2012192+3.55%
Dec 31, 2011186

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)